Skip to main content

Table 2 An overview of cohort studies or randomized controlled trials regarding outcomes of PVT in cirrhotic patients who did not receive any antithrombotic treatment

From: Transient portal vein thrombosis in liver cirrhosis

First author, year (region)

Type of study

Enrollment period

Target population

Follow-up duration

Degree of PVT

Location of PVT

No. Pts

Severity of liver cirrhosis

Proportion of HCC

No. spontaneous recanalization or improvement

No. thrombus progression

Hidaka, 2018 [26] (Japan)

Multi-center, randomized, double-blind, placebo-controlled, full-text

Oct 2014 – Mar 2016

LC with PVT

21 ± 3 days

> 50% of the cross-sectional lumen of the MPV, portal vein branches, SMV, or SV

MPV (n = 20)

Portal vein branch (n = 11)

SV (n = 0)

SMV (n = 5)

36

Child-Pugh A/B/C:

6/24/6

6 (16.7%)

7 (19.4%)

7 (19.4%)

Chen, 2016 [27] (China)

Single-center, retrospective, controlled,

full-text

Jan 2002 – Jun 2014

LC with PVT

Mean ± SD:

25.9 ± 23 months

(for 36 patients)

MPV (0–25%/26–50%/51–75%/76–100%): 8/2/6/20

LPV (0–50%/51–100%): 12/24

RPV (0–50%/51–100%): 11/25

SV (splenectomy/0–50%/51–100%): 20/11/5

SMV (0–50%/51–100%): 17/19

16

Child-Pugh A/B/C:

8/21/2

Mean MELD score: 8.9 ± 3.01

(for 36 patients)

0 (0%)

4 (25%)

6 (37.5%)

Nery,a 2015 [6] (France)

Multi-center, prospective, single-arm, full-text

Jun 2000 – Mar 2006

Child-Pugh A and B LC with de novo PVT

Mean ± SD:

65.2 ± 39.6 months

Non-occlusive at the first diagnosis of PVT (n = 101);

occlusive at the first diagnosis of PVT (n = 17)

NA

101b

All patients had Child-Pugh A or B

0 (0%) (for baseline)

70 (70%)

89c (89%)

14 (13.8%)

Chung, 2014 [28] (Korea)

Single-center, retrospective, matched, controlled, full-text

2003 – 2014

LC with non-malignant partial PVT

NA

Partial (n = 14)

MPV (n = 9)

RPV (n = 7)

LPV (n = 4)

SMV (n = 2)

14

Child-Pugh A/B/C:

7/6/1

8 (57.1%)

5 (36%)

3 (21.4%)

Girleanu, 2014 [7] (Romania)

Single-center, prospective,

single-arm,

full-text

Jan 2011 – Oct 2013

LC with non-malignant partial PVT

Mean ± SD (range):

20.22 ± 8.61

(4–31) months

Partial

PV (n = 18)

PV + SMV (n = 11)

PV + SMV + SV (n = 1)

22

Child-Pugh A/B/C:

7/9/6

Mean MELD score:

12.73 ± 4.34

0 (0%)

5 (22.73%)

6 (27.27%)

Risso, 2014 [29] (Italy)

Single-center,

retrospective,

controlled,

abstract

2005 – 2011

LC with pre-LT non-neoplastic PVT

NA

NA

NA

20

NA

NA

8 (40%)

NA

John, 2013 [8] (USA)

Single-center, prospective,

single-arm,

full-text

Jul 2004 – Jun 2009

LC awaiting LT and PVT

> 6 months in all patients

Partial (n = 38);

occlusive (n = 32)

MPV, not SMV

70

Mean MELD score:

14.4 ± 5.0 (for 47 pts. with baseline PVT);

15.3 ± 6.7 (for 23 pts. with new PVT)

0 (0%)

22 (31.4%)

3 (4.3%)

Maruyama, 2013 [9] (Japan)

Single-center, retrospective,

single-arm,

full-text

Jan 1998 – May 2009

LC with de novo PVT

Mean ± SD (range):

65.2 ± 39.6 (0.87–136.4) months

Partial (n = 31);

occlusive (n = 11)

Intrahepatic PV (n = 8)

MPV (n = 15)

SV (n = 6)

MPV + intrahepatic PV (n = 9)

MPV + SV (n = 2)

MPV + SV + intrahepatic PV (n = 2)

42

Child-Pugh A/B/C:

14/22/6

Median MELD score: 10.6

0 (0%)

20 (47.6%)

3 (7.2%)

Caracciolo, 2013 [30] (Italy)

Single-center, retrospective, matched, controlled, abstract

NA

LC with partial PVT

6–12 months

Occlusion< 50% (n = 14)

NA

14

All patients had Child-Pugh A or B (no patient had Child-Pugh C)

0 (0%)

8 (57.6%)

NA

Luca, 2012 [10] (Italy)

Single-center, retrospective, single-arm, full-text

Jan 2004 – Dec 2009

LC with non-malignant, extrahepatic, partial PVT

Mean: 27 months;

3–6 months (n = 8);

6–12 months (n = 8);

12–24 months (n = 9);

> 24 months (n = 19)

Occlusion:

< 25% (n = 8)

25–50% (n = 11)

50–75% (n = 14)

75–90% (n = 9)

MPV (n = 15)

MPV + SMV (n = 18)

MPV + SMV + SV (n = 9)

42

Mean Child-Pugh score: 8.1 ± 1.9

Mean MELD score:

12.1 ± 2.9

0 (0%)

19 (45%)

20 (48%)

Senzolo, 2012 [31] (UK)

Single-center, prospective, controlled, full-text

Jan 2007 – Jan 2008

LC with PVT

Mean:

22.53 months

CTPV (n = 3)

complete (n = 4)

partial (n = 14)

Intrahepatic PV (n = 5)

MPV (n = 21)

SMV (n = 4)

SV (n = 1)

21

Child-Pugh A/B/C:

5/9/7

Mean MELD score:

13.7 ± 3.6

0 (0%)

1 (5%)

15 (71.4%)

Garcovich, 2011 [32] (Italy)

Single-center, retrospective, matched, controlled, abstract

NA

LC with PVT

NA

Occlusion> 75% (n = 3)

NA

15

All patients had Child-Pugh A or B (no patient had Child-Pugh C)

0 (0%)

5 (33%)

NA

Francoz, 2005 [33] (France)

Single-center, retrospective, controlled, full-text

Jan 1996 – Dec 2001

LC awaiting LT and partial PVT

NA

Partial (n = 10)

MPV (n = 6)

RPV (n = 4)

LPV (n = 3)

10

Child-Pugh A/B/C:

2/6/2

Mean MELD score: 11.8 ± 6.2

2/38 (5.3%)

(for 38 patients with SVT)

0 (0%)

6 (60%)

De Santis 2001 [34] (Italy)

Single-center, retrospective, single-arm, abstract

Jan 1996 – Dec 1999

LC with PVT and without HCC

NA

NA

NA

21

NA

0 (0%)

7 (33%)

NA

  1. Abbreviations: CT computed tomography, CTPV cavernous transformation of the portal vein, HCC hepatocellular carcinoma, LC liver cirrhosis, LPV left portal vein, LT liver transplantation, MELD Model for End-Stage Liver Disease, MPV main portal vein, NA not available, PV portal vein, PVT portal vein thrombosis, RPV right portal vein, SD standard deviation, SMV superior mesenteric vein, SV splenic vein, SVT splanchnic vein thrombosis
  2. aSix patients with PVT received anticoagulation
  3. bChange of PVT in 101 patients with non-occlusive PVT, rather than those with occlusive PVT, was reported in the text
  4. cNumber of patients after adding 19 patients with PVT in whom thrombus spontaneously disappeared and then reappeared